Physician

Robert J Willard, MD

According to 2025 Medicare claims, Robert Willard, MD (NPI: 1427097427) practices dermatology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is DERMATOLOGY AND MOHS SURGERY CENTER PC (NPI: 1629279310; TIN: 36-4596422) and primary practice location at 18901-2622.

Willard's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 730 traditional Medicare patients, billed 12,269 HCPCS/CPT codes, and received $1,134,065 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 634 prescription claims across 405 beneficiaries totaling $15,145 in drug costs, led by Sumatriptan Succinate (Sumatriptan Succinate). 2019 DME data shows 40 claims. Open Payments data shows 44 records totaling $707. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $19,158 and ending at $15,145. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	902	6,414	$1,286,300
2016	959	7,345	$1,041,644
2017	1,966	12,611	$1,145,972
2018	1,527	11,525	$1,152,184
2019	1,283	9,001	$1,140,588
2020	1,005	11,599	$993,273
2021	676	10,456	$827,164
2022	655	6,849	$830,376
2023	736	9,842	$925,690
2024	730	12,269	$1,134,065

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	254	408	$19,158
2016	266	456	$88,748
2017	272	518	$79,740
2018	290	499	$24,475
2019	272	472	$73,734
2020	188	351	$171,301
2021	237	382	$12,983
2022	321	528	$20,420
2023	381	577	$72,849
2024	405	634	$15,145

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	38	44	$15,092
2019	40	40	$19,558
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	364	446	$473
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	243	346	$367
11102	Biopsy of related skin growth, first growth	192	242	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	260	314	$68
17000	Destruction of precancer skin growth, 1 growth	204	247	$40

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sumatriptan Succinate	Sumatriptan Succinate	12	480	$6,422
Clobetasol Propionate	Clobetasol Propionate	48	1,393	$1,701
Doxycycline Hyclate	Doxycycline Hyclate	137	1,557	$1,026
Cephalexin	Cephalexin	184	1,277	$673
Fluorouracil	Fluorouracil	12	360	$598

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$707	MIMEDX Group, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert J. Willard, MD?

Tedicare shows public-source Medicare data for Robert J. Willard, MD (NPI 1427097427), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert J. Willard, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert J. Willard, MD?

Robert J. Willard, MD is linked to DERMATOLOGY AND MOHS SURGERY CENTER PC (billing NPI 1629279310) in the available physician profile data.

Does Robert J. Willard, MD have Open Payments data?

Robert J. Willard, MD has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.